knowcompoundsmethylphenidate
Specimen compound organic compound
Methylphenidate
- Formula
- C14H19NO2
- Molar mass
- 233.307 g/mol
- ChEBI
- CHEBI:6887
↑ raised 2 findings in 2 endpoints · – no difference found 3 in 3
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 0
- Limited
- 1
- Very limited
- 4
- Insufficient
- 0
Methylphenidate
Most findings
- Health-related quality of life×2
- Hamilton Depression Rating Scale (HDRS) total score×1
- Serious adverse event incidence×1
- Working memory performance×1
2 reference statements, not drawn · 29 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Working memory performance
- Health-related quality of lifecontested
- Hamilton Depression Rating Scale (HDRS) total score
- Serious adverse event incidence
02 · contested · 1 endpoint
Where the findings disagree
012 findings
Health-related quality of life
03 · findings
What methylphenidate moved, and by how much
- OR odds ratio · RR risk ratio · MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
5 shown
- Working memory performanceMoved: raisesEffect, as reportedOR1.67[1.09 to 2.57]Evidence: LimitedPaper: PMID 399307132025
- Who
- Healthy adults aged 21-45 years; single 10 mg dose against placebo in a randomised double-blind crossover with one-week washout; main effect of treatment pooled over the 20-minute and 130-minute assessments
- Dose studied
- 10 mg methylphenidate (Ritalin), single dose
A significant main effect of treatment was observed for numeric working memory accuracy, whereby accuracy improved (better performance: F(1,96) = 8.76, p = 0.004) following methylphenidate (M = 96.47, SD ± 2.83) administration relative to placebo (M = 94.45, SD ± 4.43, with an odds ratio of 1.67 (95%CI: 1.09–2.57).).”
Quoted verbatim from Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double-Blind, Placebo-Controlled Study.crossoverPermalink - Serious adverse event incidenceMoved: no difference foundEffect, as reportedRR0.8[0.39 to 1.67]Evidence: Very limitedPaper: PMID 413423062025
- Who
- children and adolescents with ADHD; primary outcome (serious adverse events) · n = 3,673
- Dose studied
- not reported
Methylphenidate may not affect serious adverse events (risk ratio (RR) 0.80, 95% CI 0.39 to 1.67; I² = 0%; 26 trials, 3673 participants; very low-certainty evidence).”
Quoted verbatim from Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).meta-analysisPermalink - Hamilton Depression Rating Scale (HDRS) total scoreMoved: no difference foundEffect, as reportedMD2.8[−0.09 to 5.69]Evidence: Very limitedPaper: PMID 334600482021
- Who
- adults with ADHD, immediate-release methylphenidate versus placebo; secondary outcome (depression) · n = 19
- Dose studied
- not reported
There is no clear evidence of an effect on anxiety (MD -0.20, 95% CI -4.84 to 4.44; 1 trial, 19 participants; change scores; Hamilton Anxiety Scale (HAM-A; scored from 0 to 56); very low-certainty evidence) or depression (MD 2.80, 95% CI -0.09 to 5.69; 1 trial, 19 participants; change scores; Hamilton Depression Scale (HAM-D; scored from 0 to 52); very low-certainty evidence) in analyses comparing IR methylphenidate with placebo.”
Quoted verbatim from Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.RCTPermalink - Health-related quality of lifecontestedMoved: raisesEffect, as reportedSMD0.61[0.42 to 0.8]Evidence: Very limitedPaper: PMID 265995762015
- Who
- Children and adolescents aged 18 years or younger with ADHD, parent-reported quality of life, meta-analysis of three trials against placebo or no intervention
- Dose studied
- not reported
The change reported in a meta-analysis of three trials corresponds to a MD of 8.0 points (95% CI 5.49 to 10.46) on the CHQ, which suggests that methylphenidate may improve parent-reported quality of life (SMD 0.61, 95% CI 0.42 to 0.80; 3 trials, 514 participants; very low-quality evidence).”
Quoted verbatim from Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).meta-analysisPermalink - Health-related quality of lifecontestedMoved: no difference foundEffect, as reportedSMD0.4[−0.03 to 0.83]Evidence: Very limitedPaper: PMID 413423062025
- Who
- children and adolescents with ADHD; secondary outcome (quality of life), instrument not named by the review · n = 608
- Dose studied
- not reported
Methylphenidate may improve teacher-rated general behaviour versus placebo (SMD -0.62, 95% CI -0.91 to -0.33; I² = 68%; 7 trials 792 participants; very low-certainty evidence), but may not affect quality of life (SMD 0.40, 95% CI -0.03 to 0.83; I² = 81%; 4 trials, 608 participants; very low-certainty evidence).”
Quoted verbatim from Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).meta-analysisPermalink
No row matches these filters.
No dose is advised.
- OR odds ratio · RR risk ratio · MD mean difference · SMD standardised mean difference. Brackets: the interval as reported.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
04 · identity
Structure
- Charge
- 0
- 2D depiction
- A class in ChEBI, no single structure
What the reference databases state
- Reference statements
- 201 Compounddexmethylphenidate, methyl (S)-phenyl[(S)-piperidin-2-yl]acetateinferred, one hop from methylphenidate
2Reference statements
What the reference databases state
Evidence keyStatements
2 statements
methylphenidate is converted to each
- CompoundChEBI CHEBI:6887Inferred only
- CompoundChEBI CHEBI:6887Inferred only
06 · the record
Sources
1,138
papers screened for methylphenidate
- admitted
- 5
- read and discarded
- 207
- not read yet
- 926
Sources cited
4 papers · 5 findings
1 admitted at screening, no finding yet